Fredun Pharmaceuticals Soars to All-Time High, Signaling Unprecedented Growth and Market Confidence

Fredun Pharmaceuticals has reached an all-time high, with its stock price hitting Rs. 1696 on October 23, 2025. This milestone reflects the company's robust performance in the pharmaceuticals and biotechnology sector, particularly as it has consistently reported positive results over the last five quarters. The latest quarterly net sales reached Rs. 119.85 crore, marking a significant growth of 52.06%. Additionally, the company has demonstrated impressive operating profit growth of 56.18%, contributing to a remarkable annual net sales growth rate of 38.16%.
Despite a slight underperformance today, with a decrease of 0.05%, Fredun Pharmaceuticals has shown strong momentum over the past month, with a 35.11% increase compared to the Sensex's 3.76%. Over the past year, the stock has generated a return of 124.32%, significantly outperforming the broader market. The company's attractive valuation, characterized by a return on capital employed (ROCE) of 16.8 and a favorable enterprise value to capital employed ratio of 3.1, further underscores its strong market position. As Fredun Pharmaceuticals continues to thrive, its all-time high achievement marks a significant milestone in its growth trajectory.